Safety and Efficacy of COVID-19 Convalescent Plasma in Severe Pulmonary Disease: A Report of 17 Patients

Authors

Priya Pal, Tulane University
Moayed Ibrahim, Tulane University
Alex Niu, Tulane University
Kevin J. Zwezdaryk, Tulane University
Elise Tatje, Tulane University School of Medicine
William R. Robinson, Tulane University School of Medicine
Leta Ko, Tulane University School of Medicine
Ishwarya Satyavarapu, Tulane University School of Medicine
Wallace E. Jones, Tulane University
Adeem Nachabe, LSU Health Sciences Center- New OrleansFollow
Alfred Luk, Tulane University
David M. Mushatt, Tulane University
Karin Halvorson, Tulane University
Joshua L. Denson, Tulane University
Charles C. Smith, University Medical Center-LCMC Health
Francesco Simeone, Tulane University
Gaynelle Davis, Tulane University School of Medicine
Sukhmani K. Gill, Tulane University
April McDougal, Tulane University
Aniko S. Vigh, Tulane University School of Medicine

Document Type

Letter to the Editor

Publication Date

10-19-2020

Publication Title

Transfusion Medicine

First Page

217

Last Page

220

PubMed ID

33073895

Volume

31

Issue

3

Publisher

Wiley

Recommended Citation

Pal, Priya; Ibrahim, Moayed; Niu, Alex; Zwezdaryk, Kevin J.; Tatje, Elise; Robinson, William R.; Ko, Leta; Satyavarapu, Ishwarya; Jones, Wallace E.; Nachabe, Adeem; Luk, Alfred; Mushatt, David M.; Halvorson, Karin; Denson, Joshua L.; Smith, Charles C.; Simeone, Francesco; Davis, Gaynelle; Gill, Sukhmani K.; McDougal, April; and Vigh, Aniko S., "Safety and Efficacy of COVID-19 Convalescent Plasma in Severe Pulmonary Disease: A Report of 17 Patients" (2020). School of Medicine Faculty Publications. 374.
https://digitalscholar.lsuhsc.edu/som_facpubs/374